Surrozen Inc (SRZN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $602.54M
Last updated: Nov 17, 2026 at 11:06 AM ET
Surrozen Inc (SRZN) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Surrozen reported EPS of -$4.75, below the -$1.32 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SRZN's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 21 quarters below that had an estimate, SRZN beat 9 and missed 12. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 826.61% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$4.75 | -$1.32 | -$1.33 - -$1.30 | -259.85% | Miss | N/A | 3 | 0 up, 2 down | Nov 9, 2026 | N/A |
| Jun 30, 2026 | -$0.41 | -$1.34 | N/A | +69.40% | Beat | N/A | 2 | 0 up, 2 down | Aug 6, 2026 | $5.00M |
| Mar 31, 2026 | -$4.63 | -$0.72 | -$0.72 - -$0.72 | -543.06% | Miss | -158.5% | 2 | 2 up, 0 down | May 6, 2026 | $5.00M |
| Dec 31, 2025 | -$9.62 | -$1.24 | -$1.24 - -$1.23 | -678.79% | Miss | N/A | 2 | 1 up, 0 down | Mar 23, 2026 | $528000 |
| Sep 30, 2025 | -$3.60 | -$1.17 | -$1.17 - -$1.17 | -207.69% | Miss | N/A | 1 | 1 up, 0 down | Nov 7, 2025 | $983000 |
| Jun 30, 2025 | -$1.14 | -$1.23 | -$1.23 - -$1.23 | +7.32% | Beat | N/A | 1 | 0 up, 1 down | Aug 8, 2025 | $983000 |
| Mar 31, 2025 | $7.92 | -$1.09 | -$1.09 - -$1.09 | +826.61% | Beat | N/A | 1 | 1 up, 0 down | May 9, 2025 | $983000 |
| Dec 31, 2024 | -$9.09 | -$2.70 | N/A | -236.67% | Miss | N/A | 1 | 0 up, 1 down | Mar 31, 2025 | $655000 |
| Sep 30, 2024 | -$0.44 | -$2.77 | -$2.77 - -$2.16 | +84.12% | Beat | N/A | 2 | 0 up, 0 down | Nov 6, 2024 | $10.00M |
| Jun 30, 2024 | -$7.99 | -$2.79 | -$2.79 - -$2.79 | -186.38% | Miss | N/A | 1 | 0 up, 0 down | Aug 12, 2024 | N/A |
| Mar 31, 2024 | -$4.24 | -$4.25 | -$4.25 - -$4.25 | +0.24% | Beat | N/A | 1 | 1 up, 0 down | May 8, 2024 | N/A |
| Dec 31, 2023 | -$4.41 | -$3.00 | -$4.35 - -$1.65 | -47.00% | Miss | N/A | 2 | 0 up, 0 down | Mar 27, 2024 | N/A |
| Sep 30, 2023 | -$5.10 | -$4.20 | -$4.65 - -$4.20 | -21.43% | Miss | N/A | 2 | 0 up, 0 down | Nov 8, 2023 | N/A |
| Jun 30, 2023 | -$4.65 | -$6.00 | -$6.30 - -$6.00 | +22.50% | Beat | N/A | 2 | 0 up, 0 down | Aug 9, 2023 | N/A |
| Mar 31, 2023 | -$7.20 | -$5.42 | -$5.85 - -$4.95 | -32.84% | Miss | N/A | 3 | 0 up, 0 down | May 10, 2023 | N/A |
| Dec 31, 2022 | -$0.03 | -$0.03 | N/A | -4.60% | Miss | N/A | 4 | 0 up, 0 down | Mar 22, 2023 | $12.50M |
| Sep 30, 2022 | -$5.70 | -$6.43 | -$7.20 - -$5.85 | +11.35% | Beat | N/A | 4 | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$6.00 | -$6.90 | N/A | +13.04% | Beat | N/A | N/A | 0 up, 0 down | Aug 11, 2022 | N/A |
| Mar 31, 2022 | -$3.45 | -$8.10 | -$9.30 - -$6.45 | +57.41% | Beat | N/A | 3 | 0 up, 0 down | May 11, 2022 | N/A |
| Dec 31, 2021 | -$0.60 | -$0.44 | -$0.52 - -$0.40 | -36.36% | Miss | N/A | 3 | N/A | Mar 24, 2022 | N/A |
| Sep 30, 2021 | -$7.65 | -$5.85 | -$5.85 - -$5.70 | -30.77% | Miss | N/A | 3 | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 15, 2021 | N/A |
| Mar 31, 2021 | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2021 | N/A |
| Dec 31, 2020 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Jan 4, 2021 | N/A |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$6.44, after -$21.76 the year before. It was -$8.94 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years below with reported EPS.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$6.44 | N/A |
| Dec 31, 2024 | -$21.76 | N/A |
| Dec 31, 2023 | -$21.36 | N/A |
| Dec 31, 2022 | -$15.18 | N/A |
| Dec 31, 2021 | -$8.94 | N/A |
| Dec 31, 2020 | Not reported | N/A |
Frequently Asked Questions About SRZN
Did SRZN beat earnings estimates last quarter?
No. Surrozen reported EPS of -$4.75 for the quarter ended Sep 30, 2026, below the -$1.32 estimate by 259.85%.
What EPS do analysts expect from SRZN next quarter?
The consensus EPS estimate for Surrozen for the quarter ending Dec 31, 2026 is -$0.95 from 8 analysts, with estimates from -$1.28 to -$0.64.
How often does SRZN beat earnings estimates?
Surrozen beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -127.84%.
SRZN pages: Overview, Earnings, Forecast, Financials, Competitors